IBDEI01Y ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2214,0)
 ;;=Z84.81^^9^95^13
 ;;^UTILITY(U,$J,358.3,2214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2214,1,3,0)
 ;;=3^Family Hx of Genetic Disease Carrier
 ;;^UTILITY(U,$J,358.3,2214,1,4,0)
 ;;=4^Z84.81
 ;;^UTILITY(U,$J,358.3,2214,2)
 ;;=^5063392
 ;;^UTILITY(U,$J,358.3,2215,0)
 ;;=Z83.511^^9^95^15
 ;;^UTILITY(U,$J,358.3,2215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2215,1,3,0)
 ;;=3^Family Hx of Glaucoma
 ;;^UTILITY(U,$J,358.3,2215,1,4,0)
 ;;=4^Z83.511
 ;;^UTILITY(U,$J,358.3,2215,2)
 ;;=^5063382
 ;;^UTILITY(U,$J,358.3,2216,0)
 ;;=Z83.518^^9^95^12
 ;;^UTILITY(U,$J,358.3,2216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2216,1,3,0)
 ;;=3^Family Hx of Eye Disorder
 ;;^UTILITY(U,$J,358.3,2216,1,4,0)
 ;;=4^Z83.518
 ;;^UTILITY(U,$J,358.3,2216,2)
 ;;=^5063383
 ;;^UTILITY(U,$J,358.3,2217,0)
 ;;=Z83.52^^9^95^9
 ;;^UTILITY(U,$J,358.3,2217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2217,1,3,0)
 ;;=3^Family Hx of Ear Disorder
 ;;^UTILITY(U,$J,358.3,2217,1,4,0)
 ;;=4^Z83.52
 ;;^UTILITY(U,$J,358.3,2217,2)
 ;;=^5063384
 ;;^UTILITY(U,$J,358.3,2218,0)
 ;;=Z83.71^^9^95^4
 ;;^UTILITY(U,$J,358.3,2218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2218,1,3,0)
 ;;=3^Family Hx of Colonic Polyps
 ;;^UTILITY(U,$J,358.3,2218,1,4,0)
 ;;=4^Z83.71
 ;;^UTILITY(U,$J,358.3,2218,2)
 ;;=^5063386
 ;;^UTILITY(U,$J,358.3,2219,0)
 ;;=Z83.79^^9^95^8
 ;;^UTILITY(U,$J,358.3,2219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2219,1,3,0)
 ;;=3^Family Hx of Digestive System Diseases
 ;;^UTILITY(U,$J,358.3,2219,1,4,0)
 ;;=4^Z83.79
 ;;^UTILITY(U,$J,358.3,2219,2)
 ;;=^5063387
 ;;^UTILITY(U,$J,358.3,2220,0)
 ;;=Z79.1^^9^96^3
 ;;^UTILITY(U,$J,358.3,2220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2220,1,3,0)
 ;;=3^Long Term Current Use of NSAID
 ;;^UTILITY(U,$J,358.3,2220,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,2220,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,2221,0)
 ;;=Z79.52^^9^96^5
 ;;^UTILITY(U,$J,358.3,2221,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2221,1,3,0)
 ;;=3^Long Term Current Use of Systemic Steroids
 ;;^UTILITY(U,$J,358.3,2221,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,2221,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,2222,0)
 ;;=Z79.82^^9^96^2
 ;;^UTILITY(U,$J,358.3,2222,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2222,1,3,0)
 ;;=3^Long Term Current Use of Aspirin
 ;;^UTILITY(U,$J,358.3,2222,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,2222,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,2223,0)
 ;;=Z79.810^^9^96^4
 ;;^UTILITY(U,$J,358.3,2223,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2223,1,3,0)
 ;;=3^Long Term Current Use of SERMs
 ;;^UTILITY(U,$J,358.3,2223,1,4,0)
 ;;=4^Z79.810
 ;;^UTILITY(U,$J,358.3,2223,2)
 ;;=^5063337
 ;;^UTILITY(U,$J,358.3,2224,0)
 ;;=Z79.811^^9^96^1
 ;;^UTILITY(U,$J,358.3,2224,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2224,1,3,0)
 ;;=3^Long Term Current Use of Aromatase Inhibitors
 ;;^UTILITY(U,$J,358.3,2224,1,4,0)
 ;;=4^Z79.811
 ;;^UTILITY(U,$J,358.3,2224,2)
 ;;=^5063338
 ;;^UTILITY(U,$J,358.3,2225,0)
 ;;=E78.5^^9^97^5
 ;;^UTILITY(U,$J,358.3,2225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2225,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,2225,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,2225,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,2226,0)
 ;;=E66.9^^9^97^8
 ;;^UTILITY(U,$J,358.3,2226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2226,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,2226,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,2226,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,2227,0)
 ;;=E66.01^^9^97^7
 ;;^UTILITY(U,$J,358.3,2227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2227,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,2227,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,2227,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,2228,0)
 ;;=E66.3^^9^97^10
 ;;^UTILITY(U,$J,358.3,2228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2228,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,2228,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,2228,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,2229,0)
 ;;=I10.^^9^97^6
 ;;^UTILITY(U,$J,358.3,2229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2229,1,3,0)
 ;;=3^Hypertension,Essential Primary
 ;;^UTILITY(U,$J,358.3,2229,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,2229,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,2230,0)
 ;;=I25.2^^9^97^9
 ;;^UTILITY(U,$J,358.3,2230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2230,1,3,0)
 ;;=3^Old Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,2230,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,2230,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,2231,0)
 ;;=I25.10^^9^97^2
 ;;^UTILITY(U,$J,358.3,2231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2231,1,3,0)
 ;;=3^Athscl Hrt Disease,Native Coronary Artery,w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,2231,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,2231,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,2232,0)
 ;;=I51.9^^9^97^4
 ;;^UTILITY(U,$J,358.3,2232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2232,1,3,0)
 ;;=3^Heart Disease,Unspec
 ;;^UTILITY(U,$J,358.3,2232,1,4,0)
 ;;=4^I51.9
 ;;^UTILITY(U,$J,358.3,2232,2)
 ;;=^5007258
 ;;^UTILITY(U,$J,358.3,2233,0)
 ;;=K70.9^^9^97^1
 ;;^UTILITY(U,$J,358.3,2233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2233,1,3,0)
 ;;=3^Alcoholic Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,2233,1,4,0)
 ;;=4^K70.9
 ;;^UTILITY(U,$J,358.3,2233,2)
 ;;=^5008792
 ;;^UTILITY(U,$J,358.3,2234,0)
 ;;=R03.0^^9^97^3
 ;;^UTILITY(U,$J,358.3,2234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2234,1,3,0)
 ;;=3^Elevated B/P Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,2234,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,2234,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,2235,0)
 ;;=Z12.31^^9^98^1
 ;;^UTILITY(U,$J,358.3,2235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2235,1,3,0)
 ;;=3^Screening Mammogram for Malig Neop Breast
 ;;^UTILITY(U,$J,358.3,2235,1,4,0)
 ;;=4^Z12.31
 ;;^UTILITY(U,$J,358.3,2235,2)
 ;;=^5062685
 ;;^UTILITY(U,$J,358.3,2236,0)
 ;;=Z12.39^^9^98^8
 ;;^UTILITY(U,$J,358.3,2236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2236,1,3,0)
 ;;=3^Screening for Malig Neop Breast
 ;;^UTILITY(U,$J,358.3,2236,1,4,0)
 ;;=4^Z12.39
 ;;^UTILITY(U,$J,358.3,2236,2)
 ;;=^5062686
 ;;^UTILITY(U,$J,358.3,2237,0)
 ;;=Z11.51^^9^98^5
 ;;^UTILITY(U,$J,358.3,2237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2237,1,3,0)
 ;;=3^Screening for HPV
 ;;^UTILITY(U,$J,358.3,2237,1,4,0)
 ;;=4^Z11.51
 ;;^UTILITY(U,$J,358.3,2237,2)
 ;;=^5062674
 ;;^UTILITY(U,$J,358.3,2238,0)
 ;;=Z11.59^^9^98^16
 ;;^UTILITY(U,$J,358.3,2238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2238,1,3,0)
 ;;=3^Screening for Viral Diseases
 ;;^UTILITY(U,$J,358.3,2238,1,4,0)
 ;;=4^Z11.59
 ;;^UTILITY(U,$J,358.3,2238,2)
 ;;=^5062675
 ;;^UTILITY(U,$J,358.3,2239,0)
 ;;=Z11.3^^9^98^6
 ;;^UTILITY(U,$J,358.3,2239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2239,1,3,0)
 ;;=3^Screening for Infections w/ Sexual Mode of Transmission
 ;;^UTILITY(U,$J,358.3,2239,1,4,0)
 ;;=4^Z11.3
 ;;^UTILITY(U,$J,358.3,2239,2)
 ;;=^5062672
 ;;^UTILITY(U,$J,358.3,2240,0)
 ;;=Z11.9^^9^98^7
 ;;^UTILITY(U,$J,358.3,2240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2240,1,3,0)
 ;;=3^Screening for Infectious/Parasitic Diseases
 ;;^UTILITY(U,$J,358.3,2240,1,4,0)
 ;;=4^Z11.9
 ;;^UTILITY(U,$J,358.3,2240,2)
 ;;=^5062678
 ;;^UTILITY(U,$J,358.3,2241,0)
 ;;=Z12.2^^9^98^13
 ;;^UTILITY(U,$J,358.3,2241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2241,1,3,0)
 ;;=3^Screening for Malig Neop Respiratory Organs
 ;;^UTILITY(U,$J,358.3,2241,1,4,0)
 ;;=4^Z12.2
 ;;^UTILITY(U,$J,358.3,2241,2)
 ;;=^5062684
 ;;^UTILITY(U,$J,358.3,2242,0)
 ;;=Z12.4^^9^98^9
 ;;^UTILITY(U,$J,358.3,2242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2242,1,3,0)
 ;;=3^Screening for Malig Neop Cervix
 ;;^UTILITY(U,$J,358.3,2242,1,4,0)
 ;;=4^Z12.4
 ;;^UTILITY(U,$J,358.3,2242,2)
 ;;=^5062687
 ;;^UTILITY(U,$J,358.3,2243,0)
 ;;=Z12.12^^9^98^12
 ;;^UTILITY(U,$J,358.3,2243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2243,1,3,0)
 ;;=3^Screening for Malig Neop Rectum
 ;;^UTILITY(U,$J,358.3,2243,1,4,0)
 ;;=4^Z12.12
 ;;^UTILITY(U,$J,358.3,2243,2)
 ;;=^5062682
 ;;^UTILITY(U,$J,358.3,2244,0)
 ;;=Z12.5^^9^98^11
 ;;^UTILITY(U,$J,358.3,2244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2244,1,3,0)
 ;;=3^Screening for Malig Neop Prostate
 ;;^UTILITY(U,$J,358.3,2244,1,4,0)
 ;;=4^Z12.5
 ;;^UTILITY(U,$J,358.3,2244,2)
 ;;=^5062688
 ;;^UTILITY(U,$J,358.3,2245,0)
 ;;=Z12.11^^9^98^10
 ;;^UTILITY(U,$J,358.3,2245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2245,1,3,0)
 ;;=3^Screening for Malig Neop Colon
 ;;^UTILITY(U,$J,358.3,2245,1,4,0)
 ;;=4^Z12.11
 ;;^UTILITY(U,$J,358.3,2245,2)
 ;;=^5062681
 ;;^UTILITY(U,$J,358.3,2246,0)
 ;;=Z13.1^^9^98^4
 ;;^UTILITY(U,$J,358.3,2246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2246,1,3,0)
 ;;=3^Screening for Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,2246,1,4,0)
 ;;=4^Z13.1
 ;;^UTILITY(U,$J,358.3,2246,2)
 ;;=^5062700
 ;;^UTILITY(U,$J,358.3,2247,0)
 ;;=Z13.0^^9^98^2
 ;;^UTILITY(U,$J,358.3,2247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2247,1,3,0)
 ;;=3^Screening for Blood/Blood-Forming Organs Diseases
 ;;^UTILITY(U,$J,358.3,2247,1,4,0)
 ;;=4^Z13.0
 ;;^UTILITY(U,$J,358.3,2247,2)
 ;;=^5062699
 ;;^UTILITY(U,$J,358.3,2248,0)
 ;;=Z13.850^^9^98^15
 ;;^UTILITY(U,$J,358.3,2248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2248,1,3,0)
 ;;=3^Screening for TBI
 ;;^UTILITY(U,$J,358.3,2248,1,4,0)
 ;;=4^Z13.850
 ;;^UTILITY(U,$J,358.3,2248,2)
 ;;=^5062717
 ;;^UTILITY(U,$J,358.3,2249,0)
 ;;=Z13.6^^9^98^3
 ;;^UTILITY(U,$J,358.3,2249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2249,1,3,0)
 ;;=3^Screening for Cardiovascular Disorders
 ;;^UTILITY(U,$J,358.3,2249,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,2249,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,2250,0)
 ;;=Z13.820^^9^98^14
 ;;^UTILITY(U,$J,358.3,2250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2250,1,3,0)
 ;;=3^Screening for Osteoporosis
 ;;^UTILITY(U,$J,358.3,2250,1,4,0)
 ;;=4^Z13.820
 ;;^UTILITY(U,$J,358.3,2250,2)
 ;;=^5062713
